Monday, October 29, 2018

Granules#39; US unit gets two USFDA observations

Granules#39; US unit gets two USFDA observations "Granules Pharmaceuticals Inc, a wholly-owned foreign subsidiary of the company located in Chantilly, Virginia, US has completed USFDA (US Food and Drug Administration) inspection from October 22-26, 2018 with two Form 483 observations," the company said in a BSE filing.

from Moneycontrol Business News https://ift.tt/2OdoWkA
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

European shares log weekly losses on Iran war-linked inflation woesdrop

European markets experienced a significant downturn, with the STOXX 600 index sliding due to escalating energy inflation fears stemming from...